Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study

AIM: To evaluate the efficacy and impact of long-acting injectable (LAI) aripiprazole in patients with schizophrenia with a coexisting substance use disorder (SUD). PATIENTS AND METHODS: A multicenter, observational, descriptive and retrospective study was conducted in patients with a DSM-5 diagnosi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drugs Real World Outcomes
Autors principals: Szerman, Nestor, Basurte-Villamor, Ignacio, Vega, Pablo, Martinez-Raga, Jose, Parro-Torres, Carlos, Cambra Almerge, Julia, Grau-López, Lara, De Matteis, Mario, Arias, Francisco
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2020
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7060971/
https://ncbi.nlm.nih.gov/pubmed/32026379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-020-00178-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars